MedPath

Limitation of the Ventilatory Response to Exercise in the Master Athlete

Not Applicable
Terminated
Conditions
Healthy Volunteers
Interventions
Other: Heliox
Other: Air
Registration Number
NCT05307276
Lead Sponsor
Centre Hospitalier Universitaire de Nice
Brief Summary

It is generally accepted that the ventilatory system is not a limiting factor in physical exercise in terms of performance or exercise tolerance in healthy subjects. The ventilatory system would be oversized in relation to the stresses it has to cope with, even during maximum intensity exercise. However, some highly trained endurance athletes may be exceptions to this rule. A limitation of the expiratory flow is indeed sometimes found in these athletes, whose maximum values of ventilation can confront the mechanical limits of their ventilatory system. This phenomenon could be accentuated in elderly athletes (known as "master athletes") under the effect of structural and functional pulmonary alterations that accompany aging. Our hypothesis : What is the prevalence of exercise expiratory flow limitation in the master athlete and does it cause a decrease in physical performance via an acceleration of locomotor muscle fatigue?

Detailed Description

Not available

Recruitment & Eligibility

Status
TERMINATED
Sex
All
Target Recruitment
3
Inclusion Criteria
  • Non-smoker (active or passive) or ex-smoker of less than 5 pack-years and stopped for more than 10 years.
  • No known significant chronic pathology.
  • No symptoms suggesting a progressive pathology.
  • No contraindication to physical exercise. Normal Pulmonary Functional Test (PFT).
  • Participants affiliated to the social security system
Exclusion Criteria
  • Vulnerable persons as defined in Articles L. 1121-5 to L.1121-8 and L.1122-1-2 of the Public Health Code (e.g. persons deprived of liberty, minors, adults protected, etc.),
  • Participants with a medical contraindication to sports practice,
  • Cardiovascular, respiratory, neuromuscular and/or significant metabolic,
  • Participants with declared pathology or medical treatment,
  • Smoking or drug use,
  • Significant chronic drug treatment,
  • Lack of consent.
  • Refusal to cooperate
  • Recent rhino-bronchial infection (within last 4 weeks)
  • Mental disability

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Healthy volunteersHelioxFollowing the selection visit (#V0) to verify the inclusion and non-inclusion criteria, participants will make 2 visits (#V1 and #V2) including in particular a Respiratory Functional Exploration (EFR) and a triangular
Healthy volunteersAirFollowing the selection visit (#V0) to verify the inclusion and non-inclusion criteria, participants will make 2 visits (#V1 and #V2) including in particular a Respiratory Functional Exploration (EFR) and a triangular
Primary Outcome Measures
NameTimeMethod
Change from baseline severity of EFL during ergocycle endurance exerciseAt inclusion and 3 months

Force developed by the quadriceps muscle in response to percutaneous electrical stimulation of the femoral nerve

Secondary Outcome Measures
NameTimeMethod
Muscle activation levelAt inclusion and 3 months

estimated by measuring electromyographic (EMG) activity

Trial Locations

Locations (1)

CHU de Nice

🇫🇷

Nice, Alpes-maritimes, France

© Copyright 2025. All Rights Reserved by MedPath